CN1938387B - Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations - Google Patents
Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations Download PDFInfo
- Publication number
- CN1938387B CN1938387B CN2005800108138A CN200580010813A CN1938387B CN 1938387 B CN1938387 B CN 1938387B CN 2005800108138 A CN2005800108138 A CN 2005800108138A CN 200580010813 A CN200580010813 A CN 200580010813A CN 1938387 B CN1938387 B CN 1938387B
- Authority
- CN
- China
- Prior art keywords
- acid
- metal oxide
- surface modification
- nano particle
- carry out
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229910044991 metal oxide Inorganic materials 0.000 title claims abstract description 45
- 150000004706 metal oxides Chemical class 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000002537 cosmetic Substances 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title abstract description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 137
- 239000000203 mixture Substances 0.000 claims description 68
- 239000011787 zinc oxide Substances 0.000 claims description 66
- 230000004048 modification Effects 0.000 claims description 40
- 238000012986 modification Methods 0.000 claims description 40
- 239000002105 nanoparticle Substances 0.000 claims description 30
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 27
- 108010064470 polyaspartate Proteins 0.000 claims description 27
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 6
- 239000011164 primary particle Substances 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 229910052684 Cerium Inorganic materials 0.000 claims description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 4
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 4
- 239000004411 aluminium Substances 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 4
- 229910052719 titanium Inorganic materials 0.000 claims description 4
- 239000010936 titanium Substances 0.000 claims description 4
- 229910052726 zirconium Inorganic materials 0.000 claims description 4
- 229910002651 NO3 Inorganic materials 0.000 claims description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 3
- 229910001507 metal halide Inorganic materials 0.000 claims description 2
- 150000005309 metal halides Chemical group 0.000 claims description 2
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 claims 2
- 239000004904 UV filter Substances 0.000 abstract 1
- -1 spraying Substances 0.000 description 54
- 239000002253 acid Substances 0.000 description 41
- 150000002148 esters Chemical class 0.000 description 36
- 239000002245 particle Substances 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 239000003795 chemical substances by application Substances 0.000 description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000000463 material Substances 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 description 16
- 150000002632 lipids Chemical class 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 239000006185 dispersion Substances 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 12
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- 229940088594 vitamin Drugs 0.000 description 12
- 229930003231 vitamin Natural products 0.000 description 12
- 235000013343 vitamin Nutrition 0.000 description 12
- 239000011782 vitamin Substances 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000003995 emulsifying agent Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- 238000001556 precipitation Methods 0.000 description 10
- 235000019156 vitamin B Nutrition 0.000 description 10
- 239000011720 vitamin B Substances 0.000 description 10
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 10
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 230000003647 oxidation Effects 0.000 description 9
- 150000003722 vitamin derivatives Chemical class 0.000 description 9
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 8
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000004408 titanium dioxide Substances 0.000 description 8
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 210000004209 hair Anatomy 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 150000002739 metals Chemical class 0.000 description 7
- 230000000474 nursing effect Effects 0.000 description 7
- 229940101267 panthenol Drugs 0.000 description 7
- 239000011619 pantothenol Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 150000002191 fatty alcohols Chemical class 0.000 description 6
- 235000020957 pantothenol Nutrition 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229930003756 Vitamin B7 Natural products 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 125000005908 glyceryl ester group Chemical group 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 229940083980 lavender extract Drugs 0.000 description 5
- 235000020723 lavender extract Nutrition 0.000 description 5
- 239000004530 micro-emulsion Substances 0.000 description 5
- 150000003014 phosphoric acid esters Chemical class 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 229920000151 polyglycol Polymers 0.000 description 5
- 239000010695 polyglycol Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 235000011912 vitamin B7 Nutrition 0.000 description 5
- 239000011735 vitamin B7 Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- 239000011592 zinc chloride Substances 0.000 description 5
- 235000005074 zinc chloride Nutrition 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- RIQIJXOWVAHQES-UNAKLNRMSA-N Tocoretinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C RIQIJXOWVAHQES-UNAKLNRMSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 150000002576 ketones Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 4
- 229940048848 lauryl glucoside Drugs 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- SERHXTVXHNVDKA-UHFFFAOYSA-N pantolactone Chemical compound CC1(C)COC(=O)C1O SERHXTVXHNVDKA-UHFFFAOYSA-N 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 229950010156 tretinoin tocoferil Drugs 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- NQBWNECTZUOWID-UHFFFAOYSA-N (E)-cinnamyl (E)-cinnamate Natural products C=1C=CC=CC=1C=CC(=O)OCC=CC1=CC=CC=C1 NQBWNECTZUOWID-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical class OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 150000004703 alkoxides Chemical class 0.000 description 3
- UBNYRXMKIIGMKK-UHFFFAOYSA-N amiloxate Chemical compound COC1=CC=C(C=CC(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000000908 ammonium hydroxide Substances 0.000 description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N anhydrous gallic acid Natural products OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 239000012752 auxiliary agent Substances 0.000 description 3
- 150000008366 benzophenones Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- NQBWNECTZUOWID-QSYVVUFSSA-N cinnamyl cinnamate Chemical compound C=1C=CC=CC=1\C=C/C(=O)OC\C=C\C1=CC=CC=C1 NQBWNECTZUOWID-QSYVVUFSSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 150000008131 glucosides Chemical class 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000004816 latex Substances 0.000 description 3
- 229920000126 latex Polymers 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 3
- 229940115458 pantolactone Drugs 0.000 description 3
- SIEVQTNTRMBCHO-UHFFFAOYSA-N pantolactone Natural products CC1(C)OC(=O)CC1O SIEVQTNTRMBCHO-UHFFFAOYSA-N 0.000 description 3
- 239000003495 polar organic solvent Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 235000021286 stilbenes Nutrition 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 230000008719 thickening Effects 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- 239000012049 topical pharmaceutical composition Substances 0.000 description 3
- 229960004418 trolamine Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 239000007762 w/o emulsion Substances 0.000 description 3
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 2
- SRUQARLMFOLRDN-UHFFFAOYSA-N 1-(2,4,5-Trihydroxyphenyl)-1-butanone Chemical compound CCCC(=O)C1=CC(O)=C(O)C=C1O SRUQARLMFOLRDN-UHFFFAOYSA-N 0.000 description 2
- MEZZCSHVIGVWFI-UHFFFAOYSA-N 2,2'-Dihydroxy-4-methoxybenzophenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1O MEZZCSHVIGVWFI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- QGZGESUWFVPQPL-UHFFFAOYSA-N C(C)N(CC)C1=C(C(=C(C=C1)CCCCCC)C(C1=CC=CC=C1)=O)O Chemical compound C(C)N(CC)C1=C(C(=C(C=C1)CCCCCC)C(C1=CC=CC=C1)=O)O QGZGESUWFVPQPL-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 108010087806 Carnosine Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- DBJUEJCZPKMDPA-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O DBJUEJCZPKMDPA-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 2
- 125000005210 alkyl ammonium group Chemical group 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012874 anionic emulsifier Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229960003237 betaine Drugs 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940036350 bisabolol Drugs 0.000 description 2
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical class O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 125000001033 ether group Chemical group 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- RBNPOMFGQQGHHO-UHFFFAOYSA-N glyceric acid Chemical compound OCC(O)C(O)=O RBNPOMFGQQGHHO-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960004232 linoleic acid Drugs 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 229940059574 pentaerithrityl Drugs 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 235000020245 plant milk Nutrition 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000223 polyglycerol Chemical class 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical class [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 150000003751 zinc Chemical class 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- LAXXPOJCFVMVAX-ZETCQYMHSA-N (2s)-2-amino-4-butylsulfanylbutanoic acid Chemical compound CCCCSCC[C@H](N)C(O)=O LAXXPOJCFVMVAX-ZETCQYMHSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- FCGXLCNBWYIEAA-UHFFFAOYSA-N 1,3-benzothiazol-6-ylmethanamine Chemical compound NCC1=CC=C2N=CSC2=C1 FCGXLCNBWYIEAA-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- KJIKRRCCDJRVSX-UHFFFAOYSA-N 1-phenylpentane-1,1-diol Chemical compound CCCCC(O)(O)C1=CC=CC=C1 KJIKRRCCDJRVSX-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- RMFFCSRJWUBPBJ-UHFFFAOYSA-N 15-hydroxypentadecyl benzoate Chemical compound OCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RMFFCSRJWUBPBJ-UHFFFAOYSA-N 0.000 description 1
- TXBCBTDQIULDIA-UHFFFAOYSA-N 2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(CO)(CO)COCC(CO)(CO)CO TXBCBTDQIULDIA-UHFFFAOYSA-N 0.000 description 1
- NRFPYWJROSZLFM-UHFFFAOYSA-N 2-butylthionine Chemical compound CCCCC1=CC=CC=CC=CS1 NRFPYWJROSZLFM-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- 150000005418 4-aminobenzoic acid derivatives Chemical class 0.000 description 1
- NSISJFFVIMQBRN-UHFFFAOYSA-N 5-(hydroxymethyl)oxolan-2-one Chemical compound OCC1CCC(=O)O1 NSISJFFVIMQBRN-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- KGCMBLUUGYVISC-UHFFFAOYSA-N 9-propylheptadecan-9-amine Chemical compound CCCCCCCCC(CCC)(CCCCCCCC)N KGCMBLUUGYVISC-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical class CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- WNCAVNGLACHSRZ-KAMYIIQDSA-N Allithiamine Chemical compound C=CCSSC(/CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-KAMYIIQDSA-N 0.000 description 1
- WNCAVNGLACHSRZ-UHFFFAOYSA-N Allithiamine Natural products C=CCSSC(CCO)=C(C)N(C=O)CC1=CN=C(C)N=C1N WNCAVNGLACHSRZ-UHFFFAOYSA-N 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 241000432824 Asparagus densiflorus Species 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 125000003603 D-ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- ADFOLUXMYYCTRR-ZIAGYGMSSA-N Dihydroguaiaretic acid Natural products C1=C(O)C(OC)=CC(C[C@@H](C)[C@H](C)CC=2C=C(OC)C(O)=CC=2)=C1 ADFOLUXMYYCTRR-ZIAGYGMSSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 102100039386 Ketimine reductase mu-crystallin Human genes 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- SRBFZHDQGSBBOR-OWMBCFKOSA-N L-ribopyranose Chemical compound O[C@H]1COC(O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-OWMBCFKOSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000015511 Liquidambar orientalis Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 101000772180 Lithobates catesbeianus Transthyretin Proteins 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- KFNNRSFTPLQQPO-UHFFFAOYSA-N O1C(CC=C1)=O.O1C(CC=C1)=O Chemical compound O1C(CC=C1)=O.O1C(CC=C1)=O KFNNRSFTPLQQPO-UHFFFAOYSA-N 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 239000004870 Styrax Substances 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 239000006035 Tryptophane Substances 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 1
- UCTLHLZWKJIXJI-LXIBVNSESA-N [(3s,8r,9s,10r,13s,14s)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(Cl)=C(C=O)C[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 UCTLHLZWKJIXJI-LXIBVNSESA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000008431 aliphatic amides Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229910002064 alloy oxide Inorganic materials 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PQMKYFCFSA-N alpha-D-mannose Chemical compound OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-PQMKYFCFSA-N 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- QFWSIJKSJPEHCF-BTVCFUMJSA-N azane;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound N.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O QFWSIJKSJPEHCF-BTVCFUMJSA-N 0.000 description 1
- 239000012754 barrier agent Substances 0.000 description 1
- 229910052728 basic metal Inorganic materials 0.000 description 1
- 150000003818 basic metals Chemical class 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000005587 carbonate group Chemical group 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 229950007655 esilate Drugs 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- ATJVZXXHKSYELS-FNORWQNLSA-N ethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-FNORWQNLSA-N 0.000 description 1
- HCPOCMMGKBZWSJ-UHFFFAOYSA-N ethyl 3-hydrazinyl-3-oxopropanoate Chemical compound CCOC(=O)CC(=O)NN HCPOCMMGKBZWSJ-UHFFFAOYSA-N 0.000 description 1
- MTZQAGJQAFMTAQ-UHFFFAOYSA-N ethyl benzoate Chemical compound CCOC(=O)C1=CC=CC=C1 MTZQAGJQAFMTAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- ATJVZXXHKSYELS-UHFFFAOYSA-N ferulic acid ethyl ester Natural products CCOC(=O)C=CC1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-UHFFFAOYSA-N 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 230000001795 light effect Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- ADFOLUXMYYCTRR-OKILXGFUSA-N meso-dihydroguaiaretic acid Chemical compound C1=C(O)C(OC)=CC(C[C@H](C)[C@H](C)CC=2C=C(OC)C(O)=CC=2)=C1 ADFOLUXMYYCTRR-OKILXGFUSA-N 0.000 description 1
- XFEICBDAXKWVBZ-KGLIPLIRSA-N meso-dihydroguaiaretic acid Natural products COc1ccc(C[C@@H](C)[C@@H](C)Cc2ccc(O)c(OC)c2)cc1O XFEICBDAXKWVBZ-KGLIPLIRSA-N 0.000 description 1
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 1
- LAQFLZHBVPULPL-UHFFFAOYSA-N methyl(phenyl)silicon Chemical compound C[Si]C1=CC=CC=C1 LAQFLZHBVPULPL-UHFFFAOYSA-N 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000000593 microemulsion method Methods 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- KWUZCAVKPCRJPO-UHFFFAOYSA-N n-ethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline Chemical compound C1=CC(NCC)=CC=C1C1=NC2=CC=C(C)C=C2S1 KWUZCAVKPCRJPO-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- 230000003711 photoprotective effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108060006613 prolamin Proteins 0.000 description 1
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 150000003195 pteridines Chemical class 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000003921 pyrrolotriazines Chemical class 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical group 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-N ricinoleic acid Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC(O)=O WBHHMMIMDMUBKC-QJWNTBNXSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 150000003342 selenium Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- RJFAYQIBOAGBLC-ZEMBQCNESA-N sethotope Chemical compound C[75Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-ZEMBQCNESA-N 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 230000010512 thermal transition Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 150000003544 thiamines Chemical class 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000005829 trimerization reaction Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000004073 vulcanization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012463 white pigment Substances 0.000 description 1
- 229910052984 zinc sulfide Inorganic materials 0.000 description 1
- IPCXNCATNBAPKW-UHFFFAOYSA-N zinc;hydrate Chemical compound O.[Zn] IPCXNCATNBAPKW-UHFFFAOYSA-N 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/88—Polyamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B13/00—Oxygen; Ozone; Oxides or hydroxides in general
- C01B13/14—Methods for preparing oxides or hydroxides in general
- C01B13/145—After-treatment of oxides or hydroxides, e.g. pulverising, drying, decreasing the acidity
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
- C09C1/04—Compounds of zinc
- C09C1/043—Zinc oxide
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
- C09C1/22—Compounds of iron
- C09C1/24—Oxides of iron
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
- C09C1/36—Compounds of titanium
- C09C1/3607—Titanium dioxide
- C09C1/3676—Treatment with macro-molecular organic compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C1/00—Treatment of specific inorganic materials other than fibrous fillers; Preparation of carbon black
- C09C1/40—Compounds of aluminium
- C09C1/407—Aluminium oxides or hydroxides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09C—TREATMENT OF INORGANIC MATERIALS, OTHER THAN FIBROUS FILLERS, TO ENHANCE THEIR PIGMENTING OR FILLING PROPERTIES ; PREPARATION OF CARBON BLACK ; PREPARATION OF INORGANIC MATERIALS WHICH ARE NO SINGLE CHEMICAL COMPOUNDS AND WHICH ARE MAINLY USED AS PIGMENTS OR FILLERS
- C09C3/00—Treatment in general of inorganic materials, other than fibrous fillers, to enhance their pigmenting or filling properties
- C09C3/10—Treatment with macromolecular organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/62—Submicrometer sized, i.e. from 0.1-1 micrometer
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
- C01P2004/00—Particle morphology
- C01P2004/60—Particles characterised by their size
- C01P2004/64—Nanometer sized, i.e. from 1-100 nanometer
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention relates to surface-modified nanoparticulate metal oxides, methods for production and use thereof as UV filter in cosmetic preparations.
Description
The present invention relates to a kind of nano particle metal oxide of surface modification, their preparation method and its purposes as UV lightscreening agent in the cosmetic formulations.
Metal oxide can be used for multiple use, for example as white pigment, as catalyzer, as the component of antibiotic skin care ointment with as the activator of the vulcanization of rubber.Found that zinc oxide in small, broken bits or titanium dioxide absorb pigment as the UV-in the cosmetics barrier agent.
Within the application's scope, term " nano particle " is used to represent that median size (method by electron microscopic is measured) is the particle of 5~10000nm.
Particle diameter is applicable to as the UV absorption agent in transparent organic and inorganic mixing material, plastics, paint and the coating potentially less than the Zinc oxide nanoparticle of about 30nm.Equally, also can be used to protect the pigment dyestuff of UV-sensitivity.
Particle diameter causes the scattered light effect greater than Zinc oxide particles, particle aggregate or the particle agglomeration cognition of about 30nm, and the transparency that causes thus not expecting in the visible region reduces.Therefore, redispersibility, just the Zinc oxide nanoparticle with preparation is converted into the ability of colloid dispersed, is the important prerequisite of above-mentioned application.
Particle diameter is less than the zinc oxide of about 5 nanometers, owing to size quantization effect demonstrate absorption limit blue shift (L.Brus, J.Phys.Chem. (1986), 90,2555-2560), and therefore not too be applicable to as the UV absorption agent in the UV-A district.
The preparation of metal oxide is known, for example prepares zinc oxide by dry method and wet method.The method of traditional combustion zinc (it is known as dry method) (as Gmelin Volume 32, the 8 editions, augment volume, the 772nd page and thereafter) generates the accumulative particle of wide distribution of sizes.Though can obtain the particle diameter of sub-micrometer range in principle by grinding technics, because the shearing force that can realize is too low, so can not obtain the dispersion of median size in lower nanometer range by this powder.Zinc oxide in small, broken bits especially mainly prepares with wet chemical method by depositing technology.Precipitation in the aqueous solution generates usually and contains oxyhydroxide and/or carbonato material, and this material must thermal transition be a zinc oxide.Hot aftertreatment has adverse influence to characteristic in small, broken bits, because carried out sintering processes to particle this moment, causes the formation of micro-meter scale aggregate, only it can be decomposed into primary particle by halves by grinding.
The nano particle metal oxide can for example obtain by the microemulsion method.In this method, metal alkoxide solution is dropwise added in the water-in-oil emulsion.The hydrolysis of alkoxide takes place in the reversed phase micelle of microemulsion (its size is in nanometer range) subsequently, forms the nano particle metal oxide.The shortcoming of this method is especially: metal alkoxide is expensive starting material, the method steps that must use the preparation of emulsifying agent and the emulsion of particle diameter in nanometer range to have complexity in addition.
DE19907704 has described a kind of nano particle zinc oxide by the precipitin reaction preparation.In the method, prepare nano particle zinc oxide from acetic acid zinc solution by alkali precipitation.Can disperse to obtain colloidal sol once more by adding the zinc oxide that methylene dichloride will be centrifugal comes out.The shortcoming that the zinc oxide dispersion that this mode prepares exists is that owing to do not carry out surface modification, they do not have good long term stability.
WO00/50503 has described the nano particle zinc oxide that comprises particle diameter≤15nm and can redispersion have obtained the zinc oxide gel of colloidal sol.In the method, by adding methylene dichloride or chloroform, the throw out that will generate by the alkaline hydrolysis of zn cpds in alcohol and/or alcohol/water mixture disperses once more.The shortcoming of this moment is at water or in aqueous dispersant, can not obtain stable dispersion.
At publication Chem.Mater.2000,12,2268-74 " Synthesis andCharacterization of Poly (vinylpyrrolidone)-Modified Zinc OxideNanoparticles ", the author is among Lin Guo and the Shihe Yang, the wurtzite Zinc oxide nanoparticle that used the Polyvinylpyrolidone (PVP) surface-coated.Shortcoming herein is, use Zinc oxide particles that Polyvinylpyrolidone (PVP) applies can not redispersion in water.
WO93/21127 describes a kind of method for preparing the nano particle ceramic powder of surface modification.In the method, come the surface-modified nano particles ceramic powder by applying low molecular weight organic compound (for example propionic acid).This method can not be used for the surface modification of zinc oxide because modified-reaction be in the aqueous solution, carry out and zinc oxide be dissolved in the water-based organic acid.Therefore, this method can not be used to prepare the zinc oxide dispersion; And in this was used, zinc oxide can not be classified the possible starting material of nano ceramic powder as.
JP-A-04164814 has described a kind of method that obtains ZnO in small, broken bits, and it obtains by the precipitation in the aqueous medium at elevated temperatures, does not even use hot aftertreatment.The median size of being stated is 20~50nm, but does not point out the degree of reuniting.These particles are relatively large.Be that agglomerated is minimal, it also can cause the scattering effect do not expected in the clear applications.
It is the preparation method of the ZnO of 5~10000 nanometers that JP-A-07232919 has described particle diameter, and it prepares with the reaction of organic acid and other organic compound (as alcohol) at elevated temperatures by zn cpds.Hydrolysis takes place this moment, makes and the by product that forms (ester of the acid of using) can be distilled.Because surface modification in advance, this method can be prepared redispersible ZnO powder.But,, can not prepare the particle of mean diameter<15nm based on the disclosure of this application.Therefore, in the listed embodiment of this application, 15nm is described to minimum average primary particle diameter.
In DE3314741A1, DE3642794A1 and EP0603627A1 and WO97/16156, described especially by silicoorganic compound and come the hydrophobization metal oxide.
The metal oxide that these apply with silicone compounds, for example zinc oxide or titanium dioxide, the shortcoming of its existence is that oil-in-water prepared therefrom or water-in-oil emulsion do not have required pH stability usually.
In addition, often observe each other incompatible of the various metal oxides that apply with silicone compounds, its aggregate that may cause not expecting forms and the throwing out of variable grain.
Therefore, the objective of the invention is, the nano particle metal oxide that can generate the stable nanoparticles dispersion in water or polar organic solvent and in cosmetics oil is provided.If possible, should avoid the irreversible gathering of particulate, make and to avoid complicated grinding technics.
Nano particle metal oxide by surface modification has been realized this purpose, and wherein metal is selected from aluminium, cerium, iron, titanium, zinc and zirconium, and wherein surface modification comprises that the use poly aspartic acid applies.
Within the scope of the present invention, term " poly aspartic acid " comprises the salt of free acid and poly aspartic acid simultaneously, for example sodium, potassium, lithium, magnesium, calcium, ammonium, alkylammonium, zinc and molysite or its mixture.
The top coat that is used for the nano particle metal oxide that uses according to the present invention preferably comprises poly aspartic acid and/or its sodium salt.
Preferred implementation according to surface modification of metals oxide compound of the present invention is that wherein top coat comprises molecular weight (being measured by the gel chromatography analysis) M
wBe 1000~100000, be preferably 1000~20000, be preferably those of 1000~7000 poly aspartic acid especially.
Be that wherein the average primary particle diameter of metal oxide particle (it is measured by scanning and transmission electron microscopy) is 5~10000nm, is preferably 10~200nm, is preferably those of 10~50nm especially according to another useful embodiment of metal oxide of the present invention.
Within the scope of the present invention, described preferable alloy oxide compound is titanium dioxide and zinc oxide, is preferably zinc oxide especially.
The present invention is based on following discovery: carry out surface modification by using poly aspartic acid and/or its salt pair nano particle metal oxide, the dispersion that can realize the surface modification of metals oxide compound is the permanent stability in cosmetic formulations especially, do not have the pH that does not expect and change between the preservation period of these preparations.
The present invention further provides a kind of method for preparing the surface-modified nano particles metal oxide, wherein metal is selected from aluminium, cerium, iron, titanium, zinc and zirconium, and it passes through:
A. metal oxide is precipitated out from the aqueous solution of its a kind of metal-salt;
B. from aqueous reaction mixture, isolate sedimentary metal oxide; With
C. subsequent drying metal oxide,
Wherein, the precipitation of metal oxide is to carry out in the presence of poly aspartic acid among the method steps a..
Preferred implementation according to method of the present invention is that wherein precipitation is at molecular weight (being measured by the gel chromatography analysis) M
wBe 1000~100000, be preferably 1000~20000, be preferably 1000~7000 poly aspartic acid especially and have those that carry out down.
Metal-salt among the method steps a. can be metal halide, acetate, vitriol or nitrate.Preferred herein metal-salt is a halogenide, for example zinc chloride (II) or titanium tetrachloride; And nitrate, for example zinc nitrate (II).
The precipitation of metal oxide can be 20 ℃~100 ℃ in temperature, be preferably under 25 ℃~40 ℃ and carry out among the method steps a..
Depend on employed metal-salt, precipitation can be to carry out for 3~13 times at pH.In the zinc oxide situation, the pH during the precipitation is 7~11.
Common 0.05~the 1mol/L of the concentration of metal-salt, be preferably 0.1~0.5mol/L, be preferably 0.2~0.4mol/L especially.
Sedimentation time is generally 2~8 hours, is preferably 3~7 hours, is preferably 4~6 hours especially.
The present invention provides a kind of method for preparing the nano particle zinc oxide of surface modification especially, and it passes through:
A. in the presence of alkali metal hydroxide or ammonium hydroxide, being 25~40 ℃ in temperature is 7~11 times with pH, is settled out zinc oxide from the aqueous solution of zinc chloride (II) or zinc nitrate (II);
B. from aqueous reaction mixture, isolate sedimentary zinc oxide; With
C. subsequent drying,
Wherein the precipitation of zinc oxide is at molecular weight M among the method steps a.
wBe to carry out under the existence of 1000~7000 poly aspartic acid.
Among the method steps a. precipitation of zinc oxide can be for example with poly aspartic acid and alkali metal hydroxide or ammonium hydroxide, during especially zinc chloride (II) or zinc nitrate (II) are added in the mixture metering of NaOH to, perhaps carry out during adding poly aspartic acid solution in that zinc chloride (II) or zinc nitrate (II) aqueous solution and metal-salt oxyhydroxide or ammonium hydroxide aqueous solution are measured simultaneously.
Can be in known mode itself, for example by filtering or centrifugal sedimentary metal oxide being separated from aqueous reaction mixture.
Can the filter cake that be obtained under atmospheric pressure be dried to constant weight in known mode itself, be 40~100 ℃ for example in temperature, be preferably in 50~70 ℃ the loft drier dry.
The present invention further provides a kind of make-up composition, it comprises zinc oxide or zinc oxide dispersion according to surface-coated of the present invention.
The present invention further provides according to surface modification of metals oxide compound, the especially titanium dioxide of the inventive method preparation or the purposes of zinc oxide:
-be used for UV to protect
-as the anti-microbial activity composition.
According to preferred implementation of the present invention, the metal oxide of surface modification, especially titanium dioxide or zinc oxide, can redispersion in liquid medium and form stable dispersion.This point is useful especially, because do not need to disperse once more before further handling by prepare dispersion according to zinc oxide of the present invention, can directly handle.
According to preferred implementation of the present invention, the metal oxide of surface modification can redispersion in polar organic solvent and form stable dispersion.This point is useful especially, becomes possibility because it makes for example to be attached to equably in plastics or the film.
According to another preferred implementation of the present invention, the metal oxide of surface modification can redispersion in water and form stable dispersion.This point is useful especially, because it has opened up the possibility of for example using according to material of the present invention in cosmetic formulations (wherein with an organic solvent not being biggest advantage).Can conceivablely be the mixture of water and polar organic solvent equally.
According to preferred implementation of the present invention, the diameter of the metal oxide particle of surface modification is 10~200nm.This point is useful especially, because can guarantee good redispersibility in this distribution of sizes scope preparation.
According to special preferred implementation of the present invention, the metal oxide nanoparticles diameter is 10~50nm.This size range is useful especially, because after disperseing this Zinc oxide nanoparticle once more, the dispersion that is obtained is transparent, and can not influence color thus for example in adding cosmetic formulations to the time.And it has also brought the possibility that is used for transparent film.
When if metal oxide, especially titanium dioxide or zinc oxide are used as the UV absorption agent, the particle of diameter greater than 5nm used in suggestion, because absorption limit can be to shortwave scope skew (L.Brus under this limit, J.Phys., Chem. (1986), 90,2555-2560).
The present invention further provides a kind of make-up composition, it comprises metal oxide, especially titanium dioxide and/or zinc oxide according to surface modification of the present invention.This point is useful especially, because based on the fine dispersion of metal oxide particle, especially Zinc oxide particles, these make-up compositions can more effectively improve their Lavender Extract effect.
Another advantage is, when for example being used for skin, because small particle size can not produce friction effect, but can flexibly use, and it has brought the comfort on the skin.
Another embodiment according to this make-up composition; it is used for nursing or protection skin; in particular for sun-proof or be used to be exposed to the nursing of DT, and be emulsion, dispersion, suspensoid, aqueous tenside preparation, emulsion, lotion, frost, fragrant liquid, ointment, gel, particle, powder, paste formulation (for example as lipstick), foam, aerosol or Sprayable.Such prescription is highly suitable for topical formulations.Suitable emulsion is O/w emulsion and water-in-oil emulsion or microemulsion.This point is useful especially, because by use them in opalizer, can utilize for example UV-absorption of zinc oxide and the effect of Lavender Extract simultaneously.And foundation surface modification of metals oxide compound of the present invention is applicable to extraordinarily and is used for opalizer, is shown as transparent particle because can prepare size concerning human eye.Therefore, on skin, can not produce white mist between the usage period.
Another advantage is, a kind of in particular UV wide band of zinc oxide lightscreening agent, and its UV absorptive character can provide the opalizer that no longer needs other chemical UV lightscreening agent material.Therefore, can avoid by the degradation production of chemical lightscreening agent or the skin irritation or the anaphylactoid danger of these materials self generation, it has improved the general consistency of the opalizer of preparation in this way significantly.Usually, make-up composition is used for the topical application on the skin.Herein, the implication that topical formulations is understood is, is applicable to the fine dispersion form and preferably can activeconstituents being administered to those preparations on the skin by the form of skin absorption.For this purpose, suitable for example is water-based and water-alcohol solution, spraying, foam, foamed aerosol, ointment, hydrogel, O/W or w/o type emulsion, microemulsion or makeup viscosity preparation.
According to the preferred implementation of make-up composition of the present invention, said composition comprises carrier.Preferred carrier is water, gas, water fluid, oil, gel, emulsion or microemulsion, dispersion or its mixture.Described carrier has the advantages of good skin consistency.Hydrogel, emulsion or microemulsion are useful especially for topical formulations.
Operable emulsifying agent is nonionicization (nonionogenic) tensio-active agent, zwitterionics, amphoterics or anionic emulsifier.According in the composition of the present invention, the amount of emulsifying agent (based on said composition) can be for 0.1~10 weight %, be preferably 1~5 weight %.
Employed nonionic tensio-active agent for example can be selected from following tensio-active agent at least a:
2~30mol oxyethane and/or 0~5mol propylene oxide add to straight-chain fatty alcohol with 8~22 carbon atoms, add to the lipid acid with 12~22 carbon atoms and add to adduct on the alkylphenol that has 8~15 carbon atoms in alkyl;
Add to the C of the adduct on the glycerine by 1~30mol oxyethane
12/18-fatty acid monoester and dibasic acid esters; Monoglyceride and dibasic acid esters and sorbitan monoester and dibasic acid esters and its oxirane additive product with saturated and unsaturated fatty acids of 6~22 carbon atoms;
Have the alkyl monoglycosides of 8~22 carbon atoms and the analogue of oligoglycosides and its ethoxylation in the alkyl;
Add to adduct on Viscotrol C and/or the hydrogenated castor oil by 15~60mol oxyethane; Polyvalent alcohol, and polyglycerol esters especially, for example poly-glycerine polyricinoleate, poly-glycerine many-12-hydroxy stearic acid ester or poly-glycerine dimerization thing (polyglycerol dimerate).Same suitable is the mixture of two or more compounds in this class material;
2~15mol oxyethane adds to the adduct on Viscotrol C and/or the hydrogenated castor oil; Based on straight chain, branching, unsaturated or saturated C
6/22-lipid acid, ricinolic acid, with the 12-oxystearic acid, with the partial ester of glycerine, poly-glycerine, tetramethylolmethane, Dipentaerythritol, sugar alcohol (as Sorbitol Powder), alkyl glycoside (as methylglycoside, butyl glycoside, Plantacare APG 1200G) and polysaccharide glycosides (as Mierocrystalline cellulose);
Single, double and trialkyl phosphates and single, double and/or three-PEG-alkyl phosphate and salt thereof; Wool wax alcohol;
Polysiloxane-poly-alkyl-copolyether and corresponding derivative;
According to the mixed ester of tetramethylolmethane, lipid acid, citric acid and the Fatty Alcohol(C12-C14 and C12-C18) of German Patent 1165574, and/or has the mixed ester of lipid acid, methyl glucoside and polyvalent alcohol, preferably glycerine or the poly-glycerine of 6~22 carbon atoms; With
Polyalkylene glycol;
Trimethyl-glycine.
In addition, zwitterionics also can be used as emulsifying agent.Term " zwitterionics " is used for being illustrated in those surface active cpds that molecule has at least one quaternary ammonium group and at least one carboxylate salt or sulfonate groups.The zwitterionics of particularly suitable is so-called betaines, as glycine N-alkyl-N, and N-Dimethyl Ammonium, for example glycine cocounut oil alkyl dimethyl ammonium; Glycine N-acyl amino propyl group-N, N-Dimethyl Ammonium, for example glycine cocoyl aminopropyl Dimethyl Ammonium; With the 2-alkyl that in alkyl or acyl group, has 8~18 carbon atoms in every kind of situation-3-carboxymethyl-3-hydroxyethyl imidazole quinoline; With cocoyl amino-ethyl hydroxyethyl-carboxymethyl glycinate.Particularly preferably be known fatty acid amide derivant, name is called the cocamidopropyl betaine of CTFA.
Same suitable emulsifying agent is an amphoterics.The implication that amphoterics is understood is, in the molecule except C
8,18-alkyl or-also contain outside the acyl group at least one free amino group and at least one-COOH or-SO
3The H group and those surface active cpds that can form inner salt.Suitable examples of amphoteric surfactants is N-alkyl glycine, N-alkyl propionic acid, N-alkylamino butyric acid, N-alkyl imino dipropionic acid, N-hydroxyethyl-N-alkylamidoalkyl propyl group glycine, N-alkyl taurine, N-alkyl sarkosine, 2-alkyl aminopropionic acid and p dialkylaminobenzoic acid (having about 8~18 carbon atoms in every kind of situation in alkyl).
Particularly preferred amphoterics is N-coco alkyl amino propionic acid ester, cocoyl aminoethylamino propionic ester and C
12/18-acyl group sarkosine.Except amphoterics, quaternized emulsifying agent (quaternary emulsifier) also is suitable, those emulsifying agents of preferably quaternized ester (esterquat) type, preferable methyl-quaternised difatty acid triethanolamine ester salts.In addition, also operable anionic emulsifier is sulfated alkyl ether, direactive glyceride vitriol, lipid acid vitriol, sulfosuccinate and/or ether carboxylic acid.
Suitable oil body is for based on having 6~18, the Guerbet alcohol of the Fatty Alcohol(C12-C14 and C12-C18) of preferred 8~10 carbon atoms, straight chain C
6-C
22-lipid acid and straight chain C
6-C
22The ester of-lipid acid, branching C
6-C
13-carboxylic acid and straight chain C
6-C
22The ester of-Fatty Alcohol(C12-C14 and C12-C18), straight chain C
6-C
22The ester of-lipid acid and branching alcohol, especially 2-Ethylhexyl Alcohol, the ester of straight chain and/or branching lipid acid and polyhydroxy-alcohol (for example as propylene glycol, dimer diol or trimerization triol) and/or Guerbet alcohol is based on C
6-C
10The Witepsol W-S 55 of-lipid acid is based on C
6-C
18The liquid list of-lipid acid-/pair-, Witepsol W-S 55, C
6-C
22-Fatty Alcohol(C12-C14 and C12-C18) and/or Guerbet alcohol and aromatic carboxylic acid, especially benzoic ester, C
2-C
12-dicarboxylic acid with have the straight chain or the branching alcohol of 1~22 carbon atom or have the ester of the polyvalent alcohol of 2~10 carbon atoms and 2~6 hydroxyls, vegetables oil, the primary alconol of branching, the hexanaphthene of replacement, straight chain C
6-C
22-Fatty Alcohol(C12-C14 and C12-C18) carbonic ether, Guerbet carbonic ether, phenylformic acid and straight chain and/or branching C
6-C
22-alcohol is (as Finsolv
TN) ester, dialkyl ether, the open-loop products of epoxidized fatty acid ester and polyvalent alcohol, silicone oil, and/or aliphatics or alicyclic hydro carbons.Also operable other oil body is a silicone compounds, for example dimethyl polysiloxane, methyl phenyl silicone, cyclosiloxane, and amino-, lipid acid-, alcohol-, polyethers-, epoxy-, fluoro-, alkyl-and/or the silicone compounds of glucosides modification, it at room temperature can be liquid form or resin form.In foundation composition of the present invention, the amount of oil body (based on said composition) is 1~90 weight %, preferred 5~80 weight % and is 10~50 weight % especially.
According to particularly preferred embodiment, comprise other UV shading (photoprotective) lightscreening agent or other pigment of soluble compound form according to composition of the present invention.
Though as top as described in, by means of foundation Zinc oxide particles of the present invention, a kind of barrier compositions can be provided, said composition also can realize good UV absorptive character when not having other lightscreening agent material, but what can expect in various situations is that other UV lightscreening agent material is added in make-up composition or the barrier compositions.For example, if this point may be necessary during lay special stress on optical filtering performance.One or more other UV shading lightscreening agents can be added to according in the composition of the present invention.
In the soluble compound situation, the implication that UV shading lightscreening agent is understood is, can absorb ultraviolet ray and with the more form of long wavelength radiation such as the organic substance that heat discharges the energy that is absorbed once more.This organic substance can be oil-soluble or water miscible.
Operable oil soluble UV-B lightscreening agent for example is following material:
3-benzylidene camphor and its derivative are as 3-(4-methyl benzylidene) camphor;
The 4-aminobenzoic acid derivative, preferred 4-(dimethylamino) phenylformic acid 2-ethylhexyl, 4-(dimethylamino) phenylformic acid 2-monooctyl ester and 4-(dimethylamino) amyl benzoate;
The ester of styracin, preferred 4-methoxy cinnamic acid 2-ethylhexyl, 4-methoxy cinnamic acid propyl ester, 4-methoxy cinnamic acid isopentyl ester, 4-methoxy cinnamic acid isopentyl ester, 2-cyano group-3-phenyl-cinnamic acid 2-ethylhexyl (otocrylene);
Salicylic ester, preferred Whitfield's ointment 2-ethylhexyl, Whitfield's ointment 4-isopropyl benzyl ester, the equal menthyl ester of Whitfield's ointment;
The derivative of benzophenone, preferred 2-hydroxyl-4-methoxy benzophenone, 2-hydroxyl-4-methoxyl group-4 '-methyldiphenyl ketone, 2,2 '-dihydroxyl-4-methoxy benzophenone;
The ester of phenmethyl propanedioic acid, preferred 4-methoxyl group benzylidene malonic acid 2-ethylhexyl; Pyrrolotriazine derivatives, as 2,4,6-triphen amido (p-carbon-2 '-ethyl-1 '-hexyloxy)-1,3,5-triazines (UVINUL T-150) and dioctyl butyl amide base triazone (Uvasorb
HEB);
Propane-1,3-two ketones, 1-(4-tert-butyl-phenyl)-3-(4 '-p-methoxy-phenyl) propane-1 for example, 3-diketone.
Suitable water-soluble substances is:
2-Phenylbenzimidazole-5-sulfonic acid and its basic metal, alkaline-earth metal, ammonium, alkylammonium, silane alcohol base ammonium and its glucose ammonium salt;
The sulfonic acid of benzophenone, preferred 2-hydroxyl-4-methoxy benzophenone-5-sulfonic acid and its salt;
The sulfonic acid of 3-benzylidene camphor, for example 4-(the bornenyl methyl of 2-oxygen-3-) Phenylsulfonic acid and 2-methyl-5-(2-oxygen-3-is bornenyl) sulfonic acid and salt thereof.
The particularly preferred ester that is to use styracin, preferred 4-methoxy cinnamic acid 2-ethylhexyl, 4-methoxy cinnamic acid isopentyl ester, 2-cyano group-3-phenyl-cinnamic acid 2-ethylhexyl (otocrylene).
In addition, preferably use the derivative of benzophenone, especially 2-hydroxyl-4-methoxy benzophenone, 2-hydroxyl-4-methoxyl group-4 '-methyldiphenyl ketone, 2,2 '-dihydroxyl-4-methoxy benzophenone; The preferred propane-1 that uses, 3-two ketones, 1-(4-tert-butyl-phenyl)-3-(4 '-p-methoxy-phenyl) propane-1 for example, 3-diketone.
Suitable typical UV-A lightscreening agent is:
The derivative of benzoyl methane, 1-(4 '-tert-butyl-phenyl)-3-(4 '-p-methoxy-phenyl) propane-1 for example, 3-diketone, the 4-tertiary butyl-4 '-methoxy dibenzoyl methylmethane or 1-phenyl-3-(4 '-isopropyl phenyl) propane-1,3-diketone;
The hydroxy amino substitutive derivative of benzophenone, N for example, N-diethylamino hydroxy benzoyl-positive hexyl phenenyl manthanoate.
Certainly UV-A and UV-B lightscreening agent also use in mixture.
But operable other shading lightscreening agent also can be other insoluble pigment, as finely-dispersed metallic oxide compound and salt, and for example titanium dioxide, ferric oxide, aluminum oxide, cerium oxide, zirconium white, silicate (talcum), barium sulfate and Zinic stearas.Particle should have the mean diameter less than 100nm, is preferably 5~50nm, and is 15~30nm especially.
Except above-mentioned two groups of main shading materials, also can use the less important opalizer of anti-oxidant type, the photochemical reaction chain that it has caused when having interrupted in the UV radiation penetrates to the skin.Its typical example is superoxide dismutase, tocopherol (vitamin-E) and xitix (vitamins C).
In foundation barrier compositions of the present invention, the total content of opalizer is generally 1~20 weight %, is preferably 5~15 weight %.Can contain 1~95 weight %, be preferably 5~80 weight % and be the water of 10~60 weight % especially according to composition of the present invention.
According to particularly preferred embodiment, also comprise care substance, other cosmetic active ingredient and/or auxiliary agent and additive according to make-up composition of the present invention.
Employed other cosmetic active ingredient is skin moisturizer, antimicrobial substance and/or deodorizing or hidroschesis material especially.Its advantage that has is, can obtain other desired effects, and it helps the nursing or the processing of skin, perhaps for example is increased in the good order and condition of this make-up composition user when using said composition.
For example, on zinc oxide, water and the physiology of carrier, surface modification, the suitable solvent, also can comprise the nursing composition especially among this make-up composition, for example oil, wax, fat, increase fat material, thickening material, emulsifying agent and spices again.The care substance of vast scale is useful especially for the local preventative or cosmetic processing of skin.
Useful especially is if that except animal and plant fat and oil (it has nursing efficacy similarly in many situations), said composition also comprises other nursing component.Operable nursing activeconstituents for example is: have the Fatty Alcohol(C12-C14 and C12-C18) of 8~22 carbon atoms, especially the Fatty Alcohol(C12-C14 and C12-C18) of natural acid; Animal and plant protein hydrolyzate, especially elastin, collagen, Keratin sulfate, milk protein, soy-protein, avenin matter, pea protein, almond protein matter and aleuronat hydrolysate; Those of VITAMIN and previtamin, especially vitamin A and B series; Single-, two-and oligosaccharides; Plant milk extract; Mel extract; Ceramide; Phosphatide; Vaseline, paraffin and silicone oil; Lipid acid and aliphatic alcohol ester, especially lipid acid and monoesters with alcohol of 3~24 carbon atoms.According to preferred VITAMIN, pro-vitamin or the previtamin that uses in the composition of the present invention comprising:
VITAMIN, pro-vitamin and the previtamin of A, C, E and F series, especially 3,4-two vitamin A-2s (didehydroretinol), β-Hu Luobusu (pro-vitamin of vitamin A), palm (palmitic) ester, glucosides or the phosphoric acid ester of xitix (vitamins C) and xitix, tocopherols, especially alpha-tocopherol and its ester are as acetic ester, nicotine acid esters, phosphoric acid ester and succinate; And vitamin F, the implication of its understanding is lipid acid, especially linolic acid, linolenic acid and the arachidonic acid that refines;
The former skin smooth effect that has uniqueness valuably of vitamin A and its derivative and microorganism.
According to preferred VITAMIN, pro-vitamin or the microorganism precursor of vitamins B series or the derivative of its derivative and 2-furanone (2-furanone) of using in the composition of the present invention, wherein particularly including:
Vitamins B
1, be commonly called as thiamines, chemical name is chlorination 3-[(4 '-amino-2 '-methyl-5 '-pyrimidyl) methyl]-5-(2-hydroxyethyl)-4-methylthiazol quinoline.The consumption of preferably salt allithiamine (based on the composition gross weight) is 0.05~1 weight %.
Vitamins B
2, being commonly called as riboflavin, chemical name is 7,8-dimethyl-10-(1-D-ribosyl)-benzo [g] pteridine-2,4 (3H, 10H)-diketone (7,8-dimethyl-10-(1-D-ribityl)-benzo[g] pteridine-2,4 (3H, 10H)-dione).Pteridine is with free form, for example occur with the whey form, and can separate other pteridine derivatives from bacterium and yeast.The lyxoflavin of pteridine steric isomer (it is fit to equally according to the present invention) for can from fish meal or liver, separating and have the D-arabinose base that replaces the D-ribosyl.The consumption of riboflavin or derivatives thereof (based on the composition gross weight) is preferably 0.05~1 weight %.
Vitamins B
3, this title is through being usually used in compound nicotinic acid and niacinamide (nicotine).According to the present invention, be preferably 0.05~1 weight % at amount (based on the composition gross weight) according to niacinamide in the composition of the present invention.
Vitamins B
5(pantothenic acid and panthenol).The preferred panthenol that uses.The panthenol derivative that can use according to the present invention is ester and the ether and the positively charged ion deutero-panthenol of panthenol especially.In another preferred implementation of the present invention, except pantothenic acid or panthenol, also can use the derivative of 2-furanone.Particularly preferred derivative is commercially available material, be commonly called as the dihydro-3-hydroxyl-4 of pantolactone (pantolactone), 4-dimethyl-2 (3H)-furanone (Merck), 4-methylol-gamma-butyrolactone (Merck), 3,3-dimethyl-2-hydroxyl-gamma-butyrolactone (Aldrich) and 2,5-dihydro-5-methoxyl group-2-furanone (Merck) (comprising all steric isomers clearly).
These compounds have been given valuably according to make-up composition of the present invention and having been preserved moisture and the performance of Lavender Extract.
Preferably according in the composition of the present invention, vitamins B
5The described compound of type and the total amount of 2-furanone derivatives (based on the composition gross weight) are preferably 0.05~10 weight %.Total amount is preferably 0.1~5 weight % especially.
Vitamins B
6, its implication of understanding not is the material of homogeneous, but the derivative that the 5-methylol-2-picoline-3-is pure, its known being commonly called as is pyridoxol, Pyridoxylamine and pyridoxal.Vitamins B
6Be preferably 0.0001~1.0 weight %, especially 0.001~0.01 weight % according to the amount in the composition of the present invention.
Vitamins B
7(vitamin H) is also referred to as vitamin H or " skin VITAMIN ".Vitamin H is (3aS, 4S, 6aR) 2-oxygen six hydrogen thiophene alcohol [3,4-d] imidazoles-4-valeric acids.Vitamin H is being preferably 0.0001~1.0 weight %, especially 0.001~0.01 weight % according to the amount in the composition of the present invention.
According to the present invention, very particularly preferably be panthenol, pantolactone, niacinamide and vitamin H.
The implication that auxiliary agent and additive are understood is to be applicable to the material that improves sensation, performance and/or cosmetic properties, for example assistant for emulsifying agent, organic solvent, super fatting agent, stablizer, oxidation inhibitor, wax or fat, consistency modifiers, thickening material, suntan, VITAMIN, cationic polymers, biogenic activeconstituents, sanitas, the water solubles, solubilizing agent, dyestuff and spices.
For example, can use following auxiliary agent and additive:
Wallantoin,
Aloe vera (Aloe Vera),
Bisabolol,
Ceramide and false manifestation of vitality are through acid amides.
Oxidation inhibitor has improved the stability according to composition of the present invention valuably.Oxidation inhibitor for example is that amino acid is (as glycine; Histidine; tyrosine; tryptophane) and its derivative; imidazoles and imdazole derivatives (as urocanic acid); peptide; D for example; the L-carnosine; the D-carnosine; L-carnosine and its derivative (as anserine); carotenoid; carotene is (as alpha-carotene; β-Hu Luobusu; Lyeopene) and its derivative; Thioctic Acid and its derivative (as Thioctic acid, dihydro-); Aurothioglucose; propylthiouracil and other thio-compounds are (as thioglycerin; the sulfo-sorbyl alcohol; thioglycolic acid; the sulfo-reductone; gsh; halfcystine; Gelucystine; cystamine and its glycosyl; the N-ethanoyl; methyl; ethyl; propyl group; amyl group; butyl; lauryl; palmitoyl; oleyl; γ-flax base; cholesteryl and glyceryl ester); with its salt; Tyox B; distearylthiodi-propionate; thio-2 acid and its derivative (ester; ether; peptide; lipid; Nucleotide; nucleosides and salt); very low tolerance dose is (as sulfo group oxime compound (butyl thionine (buthionine) the sulfo group oxime of pmol/kg~pmol/kg); homocysteine sulfo group oxime; butyl thionine sulfone; five-; six-; seven thionine sulfo group oximes); and metal chelator is (as alpha-hydroxy fatty acid; EDTA; EGTA; phytinic acid; lactoferrin); alpha hydroxy acid is (as citric acid; lactic acid; oxysuccinic acid); humic acid; bile acide; bile extract; gallic acid ester is (as Propylgallate; monooctyl ester and dodecyl ester); flavonoid; catechin; bilirubin; uteroverdine and its derivative; unsaturated fatty acids and its derivative are (as gamma-linolenic acid; linolic acid; arachidonic acid; oleic acid); folic acid and its derivative; quinhydrones and its derivative (as arbutin); ubiquinone and panthenol; with its derivative; vitamins C and its derivative are (as anti-bad blood base cetylate; stearate; dipalmitate; acetic ester; Mg resists bad blood base phosphoric acid ester; sodium ascorbate and magnesium; anti-bad serium inorganic phosphorus acid esters of disodium and sulfuric ester; the anti-bad blood base of potassium is given birth to basic phosphoric acid ester; the chitosan acid ascorbyl ester); saccharosonic acid and its derivative; tocopherol and its derivative are (as the fertility yl acetate; linoleate; oleic acid ester and succinate; tocophereth-5; tocophereth-10; tocophereth-12; tocophereth-18; tocophereth-50; tocophersolan); vitamin A and derivative (as Vitamin A Palmitate 1.7 M.I.U/Gram); styrax resinoid; violaguercitrin; the coniferyl benzoic ether of rutinic acid and its derivative; disodium violaguercitrin base di-sulfate; styracin and its derivative are (as forulic acid; Ferulic acid ethylester; coffic acid); kojic acid; chitosan glycolate and salicylate; butylhydroxy toluene; the butylhydroxy phenylcarbinol; nordihydroguaiaretic acid (nordihyroguaiacic acid); go to first dihydroguaiaretic acid; THBP 2,4,5 trihydroxybutyrophenone; uric acid and its derivative; seminose and its derivative; zinc and zinc derivative (as ZnO, ZnSO
4), selenium and selenium derivative (as Sethotope), stilbene and stilbene derivatives (as oxidation stilbene and trans-oxidation stilbene).
According to the present invention, can use the suitable derivative (as salt, ester, sugar, Nucleotide, nucleosides, peptide and lipid) and the mixture (it comprises these oxidation inhibitor) of these described activeconstituentss or plant milk extract (as tea tree oil, rosemary extract and rosmarinic acid).As lipotropy, the oil soluble oxidation inhibitor in this group, preferably tocopherol and its derivative, gallic acid, flavonoid and carotenoid, and butylhydroxy toluene/phenylcarbinol.As water-soluble oxidation inhibitor, preferred amino acid (as tyrosine and halfcystine) and its derivative, and tannin, especially plant-derived those.According in the make-up composition of the present invention, the total amount of oxidation inhibitor is 0.001~20 weight %, be preferably 0.05~10 weight %, especially 0.1~5 weight % and very particularly preferably be 0.1~2 weight %.
Triterpene, especially triterpene system acid, for example ursolic acid, rosmarinic acid, betulinic acid, masticinic acid and byronolic acid.
The plain class of the monomer bitter edible plant, especially catechin and l-Epicatechol, white cell cyanidin(e) (leukoanthocyanidin), catechin polymkeric substance (catechin tannin) and Nutgalls tannin, thickening material, as gelatin, vegetable jelly such as agar, guar gum, alginate, xanthan gum, Sudan Gum-arabic, kuteera gum or angle beans, natural and synthesis of clay and sheet silicate are as wilkinite, hectorite, polynite or Laponite
, complete synthetic hydrocolloid, the Ca of for example polyvinyl alcohol, and lipid acid, Mg or Zn soap,
The plant glucosides,
Structurizing reagent, as toxilic acid and lactic acid,
Isosorbide dimethyl ether,
α, β and γ-Huan Hujing, in particular for stablizing rosinol,
Solvent, swelling and permeate substance, as ethanol, Virahol, ethylene glycol, propylene glycol, propylene glycol list ethyl ether, glycerine and Diethylene Glycol, carbonate, supercarbonate, guanidine, urea and primary, stretch phosphoric acid ester with uncle,
Perfume oil, the pigment and the dyestuff of the said composition that is used to dye,
Be used to regulate the material of pH, as α-and beta-hydroxycarboxylic acids,
Coordination agent, as EDTA, NTA, β-Beta Alanine oxalic acid and phosphoric acid,
Opalizer, as latex, vinylbenzene/PVP and vinylbenzene/acrylamide copolymer,
Pearling agent (pearlizing agent), as glycol monomethyl-and two stearates and two stearates of PEG-3,
Propelling agent, as propane/butane mix, N
2O, dme, CO
2And air.
Wallantoin, bisabolol and/or aloe vera are added to according in the make-up composition of the present invention with form of extract, also can improve this prescription the Lavender Extract, preserve moisture and the skin care performance, and be particularly preferred therefore.
As other composition,, can comprise a small amount of other tensio-active agent compatible with other composition according to make-up composition of the present invention.
The representative instance of anion surfactant is a soap, alkylbenzene sulfonate, alkane sulfonate; alkene sulfonate; alkylether sulfonate, glycerol ether sulfonate, Alpha-Methyl sulfonated ester; sulfo-fatty acid; alkyl-sulphate, fatty alcohol ether sulphate, glycerol ether sulfate; hydroxyl mixed ether vitriol; fatty acid amide (ether) vitriol, single-and double alkyl sulfo amber acid salt, single-and two alkyl sulphosuccinamate; the sulfo group tri-glyceride; the acid amides soap, ether carboxylic acid and its salt, lipid acid isethionate; the lipid acid sarcosinate; fatty acid amino esilate, N-acylamino acid, for example acyl-lactate; acyl group tartaric acid salt; acyl glutamate and acyl group asparagus fern amino acid salt; alkyl oligoglycosides vitriol, the protein fatty acid condensation product plant prod of wheat (especially based on) and alkyl (ether) phosphoric acid salt.
When if anion surfactant comprises the polyglycol ether chain, they can have common homologue distribution, distribute but preferably have narrow homologue.
The representative instance of nonionogenic tenside is the poly alkyl alcohol glycol ethers, the fatty acid polyglycol diol ester, the fatty acid amide polyglycol ether, the aliphatic amide polyglycol ether, the alkoxylate Witepsol W-S 55, mixed ether and mixed aldehyde, if be suitable for the basic oligoglycosides of alkane (alkene) and glyconic acid (glucoronic acid) derivative of partial oxidation, lipid acid N-alkyl glucose amide, the protein hydrolyzate plant prod of wheat (especially based on), polyhydric alcohol fatty acid ester, sugar ester, sorbitan ester, polysorbate and amine oxide.When if ionic surfactant pack contains the polyglycol ether chain, they can have common homologue distribution, distribute but preferably have narrow homologue.
The representative instance of cats product is quaternary ammonium compound and quaternized ester (esterquats), especially quaternary fatty acid three alkanolamine ester salt.
The representative instance of both sexes and zwitterionics is an alkyl betaine, alkylamidoalkyl trimethyl-glycine, alanine ester, amino glycinate, imidazolinium betaine and sultaine.
According to another particularly preferred embodiment, be used as barrier compositions according to make-up composition of the present invention.The advantage that it had is described in detail.
Can be used for cosmetic hair equally especially according to zinc oxide dispersion of the present invention, as shampoo, conditioning agent, purificant, hair tonic, hair gel, hair hair spray etc.Especially, the product of staying the hair life that is retained on hair or the scalp subsequent applications is a particularly suitable.In this way zinc oxide is administered on scalp and the hair, also can be used as the UV opalizer thus and/or promote the effect of its Lavender Extract on scalp.
Preferred implementation according to make-up composition of the present invention is administered to this make-up composition on the body surface pending or to be protected partly.This administration form is useful especially, because its easy processing means and got rid of wrong dosage widely.In addition, also realized extra skin care effect.Be exposed under the solar radiation iff a few part bodies, this barrier compositions also can only be administered on these parts of body in the target mode.
The present invention further provides the purposes that is used for the UV protection according to surface modification of metals oxide compound of the present invention.This point is useful especially, because owing to for example characteristic in small, broken bits and the good dispersion of surface modification zinc oxide, realized extra high UV absorptivity.
The present invention further provides according to surface modification of metals oxide compound, especially zinc oxide of the present invention purposes as the anti-microbial activity composition.This purposes of these particulate is useful especially for this purpose, because because this particulate characteristic in small, broken bits and thus obtained large specific surface have significantly improved antibiotic effect; And on the other hand, because the good distribution performance of this material, zinc oxide exists with form in small, broken bits.Can use zinc oxide with various application forms (for example frost, emulsion, washing lotion or tonic) like this, and not have any problem.
The present invention further provides a kind of pharmaceutical composition that comprises according to surface modification of metals oxide compound of the present invention.The noticeable fact of this pharmaceutical composition is, because this particulate characteristic in small, broken bits has significantly improved pharmaceutical efficacy.
In addition, the advantage that has according to pharmaceutical composition of the present invention is, because the good long of zinc oxide dispersion (top describe) for example, can add and restrain isolating stablizer and make up a prescription.Increased the consistency of this pharmaceutical composition thus extraly.
With reference to the following example, set forth the present invention in more detail.
The preparation of surface modification zinc oxide
Embodiment 1:
To comprise the aqueous solution of the poly aspartic acid of the NaOH of 8g/L and 10g/L, with zinc nitrate (II) aqueous solution of 15g/L, metering feeding is 0.15mm to volume continuously
3Mixing section in, and flow velocity is 100mL/min in every kind of situation.After reacting about 4 seconds, reaction mixture is pumped in the beaker continuously, and uses the further homogenizing of Ultra Turrax.Use after the magnetic agitation ageing 2.5 hours, form cream, filter out the zinc oxide of poly aspartic acid surface modification thus, and in 50 ℃ of loft drier dry 9 hours subsequently.
Embodiment 2:
0.2M zinc nitrate (II) solution of 1000mL is heated to 40 ℃, and under agitation in 4 hours with its metering feeding in the 0.2M NaOH solution of 1000mL (its equally also be heated to 40 ℃ and contain 20g poly aspartic acid (sodium salt) in addition).Sedimentary zinc oxide by the poly aspartic acid surface modification is filtered out, and in 50 ℃ of loft drier, carry out drying.
Embodiment 3:
0.2M zinc chloride (II) solution of 1000mL is heated to 40 ℃, and under agitation in 4 hours with its metering feeding in the 0.2M NaOH solution of 1000mL (its equally also be heated to 40 ℃ and contain 20g poly aspartic acid (sodium salt) in addition).Sedimentary zinc oxide by the poly aspartic acid surface modification is filtered out, and in 50 ℃ of loft drier, carry out drying.
Embodiment 4:
The 0.4M zinc nitrate solution of 500mL is heated to 40 ℃.By peristaltic pump, will be heated to 40 ℃ and contain the 0.8M NaOH solution of the 500mL of 40g/L poly aspartic acid in addition equally, under agitation with the speed metering feeding of 5L/h.Stirred throw out 4 hours down at 40 ℃.To filter out by the ZnO of poly aspartic acid surface modification subsequently, and at room temperature carry out drying.
Embodiment 5:
40 ℃ the 0.5M zinc nitrate solution of 200mL and the 1MNaOH solution of 200mL will all be heated to, by the speed of peristaltic pump with about 1.68L/h in every kind of situation, under agitation metering feeding is to being heated in 40 ℃ the 600mL poly aspartic acid solution (33.34g/L).Stirred throw out 2 hours down at 40 ℃.The ZnO of poly aspartic acid surface modification is passed through in centrifugation subsequently, and at room temperature carries out drying.
Embodiment 6:
The 0.4M NaOH solution (it contains the poly aspartic acid of 20g/L in addition) of 250mL is heated to 40 ℃, and in about 5 seconds and under stirring, it is oscillated in the 250mL 0.2M acetic acid zinc solution that is heated to 40 ℃ equally.Stirred throw out 2 hours down at 40 ℃.To filter by the ZnO of poly aspartic acid surface modification subsequently, and at room temperature carry out drying.
Cosmetic formulations embodiment
Preparation is according to the general operation of the preparation as emulsion of the present invention
Each of phase A and C is heated to about 85 ℃ mutually respectively.By homogenizing phase C and metal oxide are stirred to mutually among the A subsequently.After the homogenizing of simple back, stir down with emulsion cool to room temperature and bottling.All quantitative datas are all with reference to the gross weight of said preparation.
Embodiment 7:
Latex A comprises 3 weight %Uvinul
The zinc oxide of preparation among T150 and 4 weight % such as the embodiment 5.
Phase | % | INCI |
?A | 8.00 | Polycizer W 260 |
8.00 | Phenylformic acid C 12~C 15Alkyl ester | |
12.00 | Cocounut oil glyceryl ester (Cocoglyceride) | |
1.00 | Sodium?Cetearyl?Sulfate | |
4.00 | The lauryl glucoside, Polyglyceryl-2 | |
2.00 | Cetearyl?Alcohol | |
3.00 | Ethylhexyl triazone (Uvinul T150) | |
1.00 | The acetate tocoretinate | |
B | 4.0 | Zinc oxide |
C | 3.00 | Glycerine |
0.20 | Wallantoin | |
0.30 | Xanthan gum | |
0.02 | Trolamine | |
To 100 | Aqua?dem. |
Embodiment 8:
Emulsion B comprises 3 weight %Uvinul
T150,2 weight %Uvinul
The zinc oxide of preparation among A Plus and 4 weight % such as the embodiment 5.
Phase | % | INCI |
?A | 8.00 | Polycizer W 260 |
8.00 | Phenylformic acid C 12~C 15Alkyl ester |
Phase | % | INCI |
12.00 | Cocounut oil glyceryl ester | |
1.00 | Sodium?Cetearyl?Sulfate | |
4.00 | The lauryl glucoside, Polyglyceryl-2 | |
2.00 | Cetearyl?Alcohol | |
3.00 | Ethylhexyl triazone (Uvinul T150) | |
1.00 | The acetate tocoretinate | |
2.00 | Diethylamino hydroxy benzoyl hexyl benzene manthanoate (Uvinul A?Plus) | |
B | 4.0 | Zinc oxide |
C | 3.00 | Glycerine |
0.20 | Wallantoin | |
0.30 | Xanthan gum | |
1.50 | Neusilin | |
To 100 | Aqua?dem. |
Embodiment 9:
Latex A comprises 3 weight %Uvinul
The zinc oxide of preparation among T150 and 4 weight % such as the embodiment 2.
Phase | % | INCI |
A | 8.00 | Polycizer W 260 |
8.00 | Phenylformic acid C 12~C 15Alkyl ester |
Phase | % | INCI |
12.00 | Cocounut oil glyceryl ester | |
1.00 | Sodium?Cetearyl?Sulfate | |
4.00 | The lauryl glucoside, Polyglyceryl-2 | |
2.00 | Cetearyl?Alcohol | |
3.00 | Ethylhexyl triazone (Uvinul T150) | |
1.00 | The acetate tocoretinate | |
B | 4.0 | Zinc oxide |
C | 3.00 | Glycerine |
0.20 | Wallantoin | |
0.30 | Xanthan gum | |
0.02 | Trolamine | |
To 100 | Aqua?dem. |
Embodiment 10:
Emulsion B comprises 3 weight %Uvinul
T150,2 weight %Uvinul
The zinc oxide of preparation among A Plus and 4 weight % such as the embodiment 2.
Phase | % | INCI |
A | 8.00 | Polycizer W 260 |
8.00 | Phenylformic acid C 12~C 15Alkyl ester | |
12.00 | Cocounut oil glyceryl ester | |
1.00 | Sodium?Cetearyl?Sulfate |
Phase | % | INCI |
4.00 | The lauryl glucoside, Polyglyceryl-2 | |
2.00 | Cetearyl?Alcohol | |
3.00 | Ethylhexyl triazone (Uvinul T150) | |
1.00 | The acetate tocoretinate | |
2.00 | Diethylamino hydroxy benzoyl hexyl benzene manthanoate (Uvinul A?Plus) | |
B | 4.0 | Zinc oxide |
C | 3.00 | Glycerine |
0.20 | Wallantoin | |
0.30 | Xanthan gum | |
1.50 | Neusilin | |
To 100 | Aqua?dem. |
Claims (16)
1. the nano particle metal oxide of a surface modification, wherein metal is selected from aluminium, cerium, iron, titanium, zinc and zirconium, wherein:
A) surface modification comprises use molecular weight M
wBe that 1000~100000 poly aspartic acid applies; With
B) average primary particle diameter of nano particle metal oxide is 10~200nm.
2. according to the nano particle metal oxide of claim 1, it is the zinc oxide of surface modification.
3. method for preparing the nano particle metal oxide of surface modification, wherein metal is selected from aluminium, cerium, iron, titanium, zinc and zirconium, is undertaken by following steps:
A. metal oxide is precipitated out from the aqueous solution of its a kind of metal-salt;
B. from aqueous reaction mixture, isolate sedimentary metal oxide; With
C. subsequent drying metal oxide,
Wherein, carry out under the existence that is deposited in poly aspartic acid of metal oxide among the method steps a., and the average primary particle diameter of nano particle metal oxide is 10~200nm.
4. according to the method for claim 3, wherein metal-salt is metal halide, acetate, vitriol or nitrate.
5. according to the method for claim 3, wherein be deposited in molecular weight M
wBe to carry out under the existence of 1000~100000 poly aspartic acid.
6. according to the method for claim 4, wherein be deposited in molecular weight M
wBe to carry out under the existence of 1000~100000 poly aspartic acid.
7. according to the method for claim 3, wherein being deposited in temperature is to carry out under 20 ℃~100 ℃.
8. according to the method for claim 4, wherein being deposited in temperature is to carry out under 20 ℃~100 ℃.
9. according to the method for claim 5, wherein being deposited in temperature is to carry out under 20 ℃~100 ℃.
10. according to the method for claim 6, wherein being deposited in temperature is to carry out under 20 ℃~100 ℃.
11., wherein be deposited in pH and be 3~12 times and carry out according to each method in the claim 3~10.
12., be used to prepare the nano particle zinc oxide of surface modification according to each method in the claim 3~10.
13., be used to prepare the nano particle zinc oxide of surface modification according to the method for claim 11.
14. the purposes according to the nano particle metal oxide of each defined surface modification in the claim 1~2 is used to prepare cosmetic formulations.
15., be used to prepare the cosmetics barrier preparation according to the purposes of claim 14.
16. a cosmetic formulations comprises the nano particle metal oxide according to claim 1 or 2 defined surface modifications.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004016649.8 | 2004-03-31 | ||
DE200410016649 DE102004016649A1 (en) | 2004-03-31 | 2004-03-31 | Surface-modified metal oxides useful in cosmetics comprise nanoparticulate aluminum, cerium, iron, titanium, zinc or zirconium oxides coated with polyaspartic acid |
DE102004020766.6 | 2004-04-27 | ||
DE200410020766 DE102004020766A1 (en) | 2004-04-27 | 2004-04-27 | Surface-modified metal oxides useful in cosmetics comprise nanoparticulate aluminum, cerium, iron, titanium, zinc or zirconium oxides coated with polyaspartic acid |
PCT/EP2005/003217 WO2005094156A2 (en) | 2004-03-31 | 2005-03-26 | Polyasparaginic acid surface-modified metal oxides methods for production and use thereof in cosmetic preparations |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1938387A CN1938387A (en) | 2007-03-28 |
CN1938387B true CN1938387B (en) | 2010-09-29 |
Family
ID=35034116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800108138A Expired - Fee Related CN1938387B (en) | 2004-03-31 | 2005-03-26 | Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN1938387B (en) |
DE (1) | DE102004016649A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103242695B (en) * | 2013-05-05 | 2015-07-29 | 浙江师范大学 | A kind of preparation method of ZnO semiconductor nanomaterial ink |
CN105251995B (en) * | 2015-11-05 | 2017-10-10 | 北京化工大学 | A kind of preparation method of the nanometer nulvalent iron particle of spacetabs type |
CA3030443A1 (en) * | 2016-05-20 | 2017-11-23 | University Of Ottawa | Lignin-coated metal oxide nanoparticles and use thereof in cosmetic compositions |
CN108822747A (en) * | 2018-06-28 | 2018-11-16 | 芜湖市棠华建材科技有限公司 | Halogen-free anti-inflaming polyurethane sealant |
CN108715741A (en) * | 2018-06-28 | 2018-10-30 | 芜湖市棠华建材科技有限公司 | Flame-retardant polyurethane sealant |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714558A (en) * | 1993-03-02 | 1998-02-03 | Bayer Ag | Process for preparing polyaspartic acid |
CN1229353A (en) * | 1996-09-27 | 1999-09-22 | 普罗克特和甘保尔公司 | Stable photoprotective compositions |
US6174988B1 (en) * | 1999-04-07 | 2001-01-16 | National Starch & Chemical Company | Use of polyamino acid salts in water-borne adhesive applications |
US6218459B1 (en) * | 1998-05-20 | 2001-04-17 | Th. Goldschmidt Ag | Pigment pastes comprising hydrophobically modified polyaspartic acid derivatives |
-
2004
- 2004-03-31 DE DE200410016649 patent/DE102004016649A1/en not_active Withdrawn
-
2005
- 2005-03-26 CN CN2005800108138A patent/CN1938387B/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5714558A (en) * | 1993-03-02 | 1998-02-03 | Bayer Ag | Process for preparing polyaspartic acid |
CN1229353A (en) * | 1996-09-27 | 1999-09-22 | 普罗克特和甘保尔公司 | Stable photoprotective compositions |
US6218459B1 (en) * | 1998-05-20 | 2001-04-17 | Th. Goldschmidt Ag | Pigment pastes comprising hydrophobically modified polyaspartic acid derivatives |
US6174988B1 (en) * | 1999-04-07 | 2001-01-16 | National Starch & Chemical Company | Use of polyamino acid salts in water-borne adhesive applications |
Non-Patent Citations (1)
Title |
---|
Lin Guo,Shihe Yang,Chunlei Yang等.Synthesis and CharacterizationofPoly(vinylpyrrolidone)-Modified Zinc Oxide Nanoparticles.Chemistry of Materials12.2000,122268-2274. * |
Also Published As
Publication number | Publication date |
---|---|
DE102004016649A1 (en) | 2005-10-20 |
CN1938387A (en) | 2007-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Van Tran et al. | Core-shell materials, lipid particles and nanoemulsions, for delivery of active anti-oxidants in cosmetics applications: Challenges and development strategies | |
JP5089887B2 (en) | Bioactive substance-containing complex | |
EP1500385B1 (en) | Method of foam stabilization for foam cosmetic | |
CN108350012B (en) | Novel gelling agents for sugar derivatives | |
EP1072259B1 (en) | Microcapsule and method of making the same | |
KR20080111033A (en) | Casein nanoparticle | |
CN101189307A (en) | Surface-modified metal oxides, method for production and use thereof in cosmetic preparations | |
JP2007534807A (en) | Surface-modified metal oxide, process for its production and its use in cosmetic preparations | |
US20090324658A1 (en) | Cosmetic and Method for Production Thereof | |
JP2007224012A (en) | Enzymatically crosslinked protein nanoparticle | |
CN102711743A (en) | Methods of making and using compositions comprising flavonoids | |
JP2005517031A (en) | Water dispersible coenzyme Q-10 dry powder | |
US20080031906A1 (en) | Cosmetic Composition and Method for Producing the Same | |
JP2007537116A (en) | Surface-modified metal oxide, process for its production and its use in cosmetic preparations | |
CN101182299A (en) | Mydrial derivates,preparation method of mydrial derivates and cosmetics or skin medicinal composition | |
WO2016121867A1 (en) | Transdermally absorbable base material comprising lipid peptide-type compound | |
Dini | Contribution of nanoscience research in antioxidants delivery used in nutricosmetic sector | |
Poureini et al. | Loading of apigenin extracted from parsley leaves on colloidal core-shell nanocomposite for bioavailability enhancement | |
JP2010132609A (en) | Casein nanoparticle | |
Das et al. | Production and physicochemical characterization of nanocosmeceuticals | |
WO2013125708A1 (en) | Topical skin preparation and healthy skin cell activation agent | |
CN1938387B (en) | Surface-modified metal oxides, methods for production and use thereof in cosmetic preparations | |
KR20170127165A (en) | Solid emulsion bead containing titanium dioxide and a cosmetic composition for skin whitening using the same | |
JPH07291827A (en) | Production of o/w-type skin cream | |
JPH0899835A (en) | Production of milky lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100929 Termination date: 20110326 |